Skip to Content

Virtus LifeSci Biotech Clinical Trls ETF BBC

Quantitative rating as of

Morningstar’s Analysis BBC

Will BBC outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Summary

|

Weakness in Virtus LifeSci Biotech Clinical Trls ETF's Process and People Pillar ratings limits this strategy to a Morningstar Quantitative Rating of Negative. The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Unlock our full analysis with Morningstar Investor